Makidono C - Search Results

1

Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis.

Makidono C, Mizuno M, Nasu J, Hiraoka S, Okada H, Yamamoto K, Fujita T, Shiratori Y. Makidono C, et al. J Lab Clin Med. 2004 Mar;143(3):152-8. doi: 10.1016/j.lab.2003.11.004. J Lab Clin Med. 2004. PMID: 15007304

2

Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis.

Okazaki H, Mizuno M, Nasu J, Makidono C, Hiraoka S, Yamamoto K, Okada H, Fujita T, Tsuji T, Shiratori Y. Okazaki H, et al. Among authors: makidono c. J Lab Clin Med. 2004 Mar;143(3):169-74. doi: 10.1016/j.lab.2003.11.005. J Lab Clin Med. 2004. PMID: 15007307

3

Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus.

Hiraoka S, Mizuno M, Nasu J, Okazaki H, Makidono C, Okada H, Terada R, Yamamoto K, Fujita T, Shiratori Y. Hiraoka S, et al. Among authors: makidono c. J Lab Clin Med. 2004 Apr;143(4):201-6. doi: 10.1016/j.lab.2003.12.013. J Lab Clin Med. 2004. PMID: 15085078

4

Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.

Shimo K, Mizuno M, Nasu J, Hiraoka S, Makidono C, Okazaki H, Yamamoto K, Okada H, Fujita T, Shiratori Y. Shimo K, et al. Among authors: makidono c. J Gastroenterol Hepatol. 2004 Jun;19(6):643-7. doi: 10.1111/j.1440-1746.2003.03328.x. J Gastroenterol Hepatol. 2004. PMID: 15151618

5

Stool decay-accelerating factor as a marker for monitoring the disease activity during leukocyte apheresis therapy in patients with refractory ulcerative colitis.

Kohno H, Mizuno M, Nasu J, Makidono C, Hiraoka S, Inaba T, Yamamoto K, Okada H, Fujita T, Shiratori Y. Kohno H, et al. Among authors: makidono c. J Gastroenterol Hepatol. 2005 Jan;20(1):73-8. doi: 10.1111/j.1440-1746.2004.03545.x. J Gastroenterol Hepatol. 2005. PMID: 15610450

6

Therapeutic efficacy of leukocytapheresis in a pregnant woman with severe active ulcerative colitis.

Okada H, Makidono C, Takenaka R, Hiraoka S, Fujiwara A, Kato J, Kawahara Y, Kawamoto H, Mizuno M, Shiratori Y. Okada H, et al. Among authors: makidono c. Digestion. 2006;74(1):15-8. doi: 10.1159/000095478. Epub 2006 Aug 29. Digestion. 2006. PMID: 16940730

7

Centrifugal leukocytapheresis therapy for ulcerative colitis without concurrent corticosteroid administration.

Okada H, Takenaka R, Hiraoka S, Makidono C, Hori S, Kato J, Okazaki H, Kawamoto H, Mizuno M, Shiratori Y. Okada H, et al. Among authors: makidono c. Ther Apher Dial. 2006 Jun;10(3):242-6. doi: 10.1111/j.1744-9987.2006.00379.x. Ther Apher Dial. 2006. PMID: 16817788 Clinical Trial.

8

Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.

Hori S, Takaki A, Okada H, Fujiwara A, Takenaka R, Makidono C, Shiratori Y. Hori S, et al. Among authors: makidono c. J Gastroenterol Hepatol. 2006 Nov;21(11):1704-9. doi: 10.1111/j.1440-1746.2006.04267.x. J Gastroenterol Hepatol. 2006. PMID: 16984593

9

Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type.

Takenaka R, Okada H, Kato J, Makidono C, Hori S, Kawahara Y, Miyoshi M, Yumoto E, Imagawa A, Toyokawa T, Sakaguchi K, Shiratori Y. Takenaka R, et al. Among authors: makidono c. Aliment Pharmacol Ther. 2007 Apr 1;25(7):805-12. doi: 10.1111/j.1365-2036.2007.03268.x. Aliment Pharmacol Ther. 2007. PMID: 17373919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters